HRSA Publishes New FAQ on Controversial 340B Rebate Pilot Program

HRSA recently published an FAQ addressing various stakeholder inquiries about its 340B rebate pilot program.
The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Schedules Late-October Oral Arguments for Drugmaker 340B Rebate Appeals

A Washington, D.C. federal appeals court scheduled oral arguments for drugmakers' 340B rebate appeals.
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Maine Over 340B Contract Pharmacy Law; Key Lawmaker Condemns Move

Drugmakers AbbVie and Novartis recently challenged Maine's 340B contract pharmacy access law in federal court.
Two major drugmakers recently filed lawsuits challenging Maine’s new 340B contract pharmacy access law, drawing sharp criticism from an influential [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Analysis: PhRMA Member Restrictions on Health Centers Have More Than Doubled Since NACHC-PhRMA Alliance Formed

A 340B Report analysis finds that a significant number of PhRMA members placed 340B contract pharmacy restrictions on health centers after the NACHC-PhRMA alliance formed in March 2023.
The number of drugmakers that have placed 340B contract pharmacy restrictions on health centers has more than doubled since the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Rhode Island Over 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis recently filed federal lawsuits challenging Rhode Island's new 340B contract pharmacy access law.
Two large pharmaceutical companies this week filed the first federal lawsuits challenging Rhode Island’s recently enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Briefs in Colorado, Tennessee, Utah and Hawaii

Key briefs were filed this week in state 340B contract pharmacy litigation in Colorado, Tennessee, Utah and Hawaii.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi, J&J Exempt New States from 340B Contract Pharmacy Restrictions

Drugmakers Sobi and Johnson & Johnson recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access laws.
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live